Guardant Health
GH
#1552
Rank
โ‚ฌ11.42 B
Marketcap
87,96ย โ‚ฌ
Share price
-1.81%
Change (1 day)
155.53%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ0.49 Billion

According to Guardant Health 's latest financial reports the company has โ‚ฌ0.49 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Guardant Health - Cash on Hand chart (from 2017 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.80 B-23.64%
2023-12-31โ‚ฌ1.05 B12.14%
2022-12-31โ‚ฌ0.94 B14.46%
2021-12-31โ‚ฌ0.82 B-43.56%
2020-12-31โ‚ฌ1.45 B212.68%
2019-12-31โ‚ฌ0.46 B27.43%
2018-12-31โ‚ฌ0.36 B98.54%
2017-12-31โ‚ฌ0.18 B103.68%
2016-12-31โ‚ฌ90.56 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Natera
NTRA
โ‚ฌ0.89 B 79.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚ฌ0.11 B-76.06%๐Ÿ‡บ๐Ÿ‡ธ USA